Global Bloodstream Infection Testing Market Size Study & Forecast, by Product (Reagents & Consumables, Instruments), by Sample Type (Whole Blood, Blood Culture), by Technology (PCR, Mass Spectroscopy, In Situ Hybridization, Others), by End-use (Hospitals & Diagnostic Centers, Custom Laboratory Service Providers, Others), and Regional Analysis, 2023-2030
Global Bloodstream Infection Testing Market is valued at approximately USD 689.13 million in 2022 and is anticipated to grow with a healthy growth rate of more than 4.5% over the forecast period 2023-2030. Bloodstream infection testing, also known as blood culture testing, is a medical diagnostic procedure that is used to detect the presence of microorganisms, such as bacteria, fungi, and sometimes viruses, in a patient's bloodstream. It is a critical diagnostic tool in clinical medicine for identifying and managing sepsis, a severe and potentially life-threatening condition that occurs when the body's response to infection causes harm to its own tissues and organs. This plays a vital role in investigating the bacteria and pathogens accountable for bloodstream infections. There is a heightened risk of infectious diseases spreading particularly in densely populated regions with limited hygiene practices, posing a significant threat to public health. This presents a challenge for public health management, necessitating efficient diagnostic approaches to identify and contain these infections. The global rise in infectious diseases and the growing awareness and focus on infection control stand out as key drivers propelling the market growth during the estimated period.
In addition, the rise in the number of blood donation campaigns is playing a major role in supporting the market growth on a global scale. Governments around the world are implementing initiatives to reduce the incidence of healthcare-associated infections. These initiatives are driving the demand for bloodstream infection testing in hospitals and other healthcare settings. For instance, in August 2022, The U.S. Department of Health and Human Services (HHS) unveiled an initiative to boost blood and plasma donations. This initiative focuses on raising public consciousness about the significance of blood and plasma donations and fostering a culture of consistent contributions among Americans. Also, in November 2021, the Emirates Health Services (EHS) launched a Blood Donation Campaign with the objective of fostering community engagement and nurturing a culture of generosity. This initiative seeks to increase awareness about the significance of blood donation and to address the requirements of patients. Thus, this initiative promotes blood donation which further leads to an emphasis on infection control and prevention in healthcare settings, especially in the wake of healthcare-associated infections. Initiatives to curb the overuse and misuse of antibiotics, which are closely tied to the management of bloodstream infections, promote the use of targeted testing. Moreover, the rise in the development of rapid point-of-care testing solutions, as well as the increasing use of invasive medical devices presents various lucrative opportunities over the forecast years. However, the high diagnosis cost and lower investments in underdeveloped countries are hindering the market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Bloodstream Infection Testing Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increased disposable income, the presence of well-established healthcare infrastructure, favorable reimbursement policies, and a growing number of strategic endeavors and product launches by major industry players. Additionally, the surge in demand for rapid diagnostic tests, as well as growing awareness of healthcare-associated infection is further propelling the market demand across the region. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The growing investment in technological advancements and increasing number of government initiatives are significantly propelling the market demand across the region. Also, the increasing prevalence of chronic diseases, the rising aging population, along with shift towards patient-centered care and personalized medicine are further promoting the regional market expansion.
Major market players included in this report are:
BioMйrieux SA
Becton, Dickinson and Company
Cepheid.
Seegene Inc.
T2 Biosystems, Inc.
F. Hoffmann-La Roche Ltd
Siemens Healthcare GmbH
Luminex Corporation.
Bruker
Accelerate Diagnostics, Inc.
Recent Developments in the Market:
In October 2022, BD, a renowned global medical technology firm, partnered with Magnolia Medical Technologies, Inc., in a commercial agreement. This agreement is focusing on aiding U.S. hospitals in minimizing blood culture contamination, elevating the precision of testing, and, ultimately, enhancing clinical outcomes.
In July 2022, T2 Biosystems, Inc., a prominent player in the early detection of antibiotic resistance genes and pathogens causing sepsis, was granted approval by the U.S. Food and Drug Administration (FDA) for its T2Lyme Panel. This panel allows healthcare providers to expedite appropriate treatment for patients, thereby mitigating the potential adverse effects of treatment and reducing antibiotic overuse.
Global Bloodstream Infection Testing Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, Sample Type, Technology, End-use, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Reagents & Consumables
Instruments
By Sample Type:
Whole Blood
Blood Culture
By Technology:
PCR
Mass Spectroscopy
In Situ Hybridization
Others
By End-use:
Hospitals & Diagnostic Centers
Custom Laboratory Service Providers
Academic & Research Institutes
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
In addition, the rise in the number of blood donation campaigns is playing a major role in supporting the market growth on a global scale. Governments around the world are implementing initiatives to reduce the incidence of healthcare-associated infections. These initiatives are driving the demand for bloodstream infection testing in hospitals and other healthcare settings. For instance, in August 2022, The U.S. Department of Health and Human Services (HHS) unveiled an initiative to boost blood and plasma donations. This initiative focuses on raising public consciousness about the significance of blood and plasma donations and fostering a culture of consistent contributions among Americans. Also, in November 2021, the Emirates Health Services (EHS) launched a Blood Donation Campaign with the objective of fostering community engagement and nurturing a culture of generosity. This initiative seeks to increase awareness about the significance of blood donation and to address the requirements of patients. Thus, this initiative promotes blood donation which further leads to an emphasis on infection control and prevention in healthcare settings, especially in the wake of healthcare-associated infections. Initiatives to curb the overuse and misuse of antibiotics, which are closely tied to the management of bloodstream infections, promote the use of targeted testing. Moreover, the rise in the development of rapid point-of-care testing solutions, as well as the increasing use of invasive medical devices presents various lucrative opportunities over the forecast years. However, the high diagnosis cost and lower investments in underdeveloped countries are hindering the market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Bloodstream Infection Testing Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increased disposable income, the presence of well-established healthcare infrastructure, favorable reimbursement policies, and a growing number of strategic endeavors and product launches by major industry players. Additionally, the surge in demand for rapid diagnostic tests, as well as growing awareness of healthcare-associated infection is further propelling the market demand across the region. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The growing investment in technological advancements and increasing number of government initiatives are significantly propelling the market demand across the region. Also, the increasing prevalence of chronic diseases, the rising aging population, along with shift towards patient-centered care and personalized medicine are further promoting the regional market expansion.
Major market players included in this report are:
BioMйrieux SA
Becton, Dickinson and Company
Cepheid.
Seegene Inc.
T2 Biosystems, Inc.
F. Hoffmann-La Roche Ltd
Siemens Healthcare GmbH
Luminex Corporation.
Bruker
Accelerate Diagnostics, Inc.
Recent Developments in the Market:
In October 2022, BD, a renowned global medical technology firm, partnered with Magnolia Medical Technologies, Inc., in a commercial agreement. This agreement is focusing on aiding U.S. hospitals in minimizing blood culture contamination, elevating the precision of testing, and, ultimately, enhancing clinical outcomes.
In July 2022, T2 Biosystems, Inc., a prominent player in the early detection of antibiotic resistance genes and pathogens causing sepsis, was granted approval by the U.S. Food and Drug Administration (FDA) for its T2Lyme Panel. This panel allows healthcare providers to expedite appropriate treatment for patients, thereby mitigating the potential adverse effects of treatment and reducing antibiotic overuse.
Global Bloodstream Infection Testing Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, Sample Type, Technology, End-use, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Reagents & Consumables
Instruments
By Sample Type:
Whole Blood
Blood Culture
By Technology:
PCR
Mass Spectroscopy
In Situ Hybridization
Others
By End-use:
Hospitals & Diagnostic Centers
Custom Laboratory Service Providers
Academic & Research Institutes
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Bloodstream Infection Testing Market, by Region, 2020-2030 (USD Million)
1.2.2. Bloodstream Infection Testing Market, by Product, 2020-2030 (USD Million)
1.2.3. Bloodstream Infection Testing Market, by Sample Type, 2020-2030 (USD Million)
1.2.4. Bloodstream Infection Testing Market, by Technology, 2020-2030 (USD Million)
1.2.5. Bloodstream Infection Testing Market, by End-use, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL BLOODSTREAM INFECTION TESTING MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL BLOODSTREAM INFECTION TESTING MARKET DYNAMICS
3.1. Bloodstream Infection Testing Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing burden of infectious diseases
3.1.1.2. Rising number of blood donations campaign
3.1.2. Market Challenges
3.1.2.1. High diagnosis cost
3.1.2.2. Lower investments in underdeveloped countries
3.1.3. Market Opportunities
3.1.3.1. Rise in the development of rapid point-of-care testing solutions
3.1.3.2. Increasing use of invasive medical devices
CHAPTER 4. GLOBAL BLOODSTREAM INFECTION TESTING MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL BLOODSTREAM INFECTION TESTING MARKET, BY PRODUCT
5.1. Market Snapshot
5.2. Global Bloodstream Infection Testing Market by Product, Performance - Potential Analysis
5.3. Global Bloodstream Infection Testing Market Estimates & Forecasts by Product 2020-2030 (USD Million)
5.4. Bloodstream Infection Testing Market, Sub Segment Analysis
5.4.1. Reagents & Consumables
5.4.2. Instruments
CHAPTER 6. GLOBAL BLOODSTREAM INFECTION TESTING MARKET, BY SAMPLE TYPE
6.1. Market Snapshot
6.2. Global Bloodstream Infection Testing Market by Sample Type, Performance - Potential Analysis
6.3. Global Bloodstream Infection Testing Market Estimates & Forecasts by Sample Type 2020-2030 (USD Million)
6.4. Bloodstream Infection Testing Market, Sub Segment Analysis
6.4.1. Whole Blood
6.4.2. Blood Culture
CHAPTER 7. GLOBAL BLOODSTREAM INFECTION TESTING MARKET, BY TECHNOLOGY
7.1. Market Snapshot
7.2. Global Bloodstream Infection Testing Market by Technology, Performance - Potential Analysis
7.3. Global Bloodstream Infection Testing Market Estimates & Forecasts by Technology 2020-2030 (USD Million)
7.4. Bloodstream Infection Testing Market, Sub Segment Analysis
7.4.1. PCR
7.4.2. Mass Spectroscopy
7.4.3. In Situ Hybridization
7.4.4. Others
CHAPTER 8. BLOODSTREAM INFECTION TESTING MARKET, BY END-USE
8.1. Market Snapshot
8.2. Global Bloodstream Infection Testing Market by End-use, Performance - Potential Analysis
8.3. Global Bloodstream Infection Testing Market Estimates & Forecasts by End-use 2020-2030 (USD Million)
8.4. Bloodstream Infection Testing Market, Sub Segment Analysis
8.4.1. Hospitals & Diagnostic Centers
8.4.2. Custom Laboratory Service Providers
8.4.3. Academic & Research Institutes
8.4.4. Others
CHAPTER 9. GLOBAL BLOODSTREAM INFECTION TESTING MARKET, REGIONAL ANALYSIS
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Bloodstream Infection Testing Market, Regional Market Snapshot
9.4. North America Bloodstream Infection Testing Market
9.4.1. U.S. Bloodstream Infection Testing Market
9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
9.4.1.2. Sample Type breakdown estimates & forecasts, 2020-2030
9.4.1.3. Technology breakdown estimates & forecasts, 2020-2030
9.4.1.4. End-use breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Bloodstream Infection Testing Market
9.5. Europe Bloodstream Infection Testing Market Snapshot
9.5.1. U.K. Bloodstream Infection Testing Market
9.5.2. Germany Bloodstream Infection Testing Market
9.5.3. France Bloodstream Infection Testing Market
9.5.4. Spain Bloodstream Infection Testing Market
9.5.5. Italy Bloodstream Infection Testing Market
9.5.6. Rest of Europe Bloodstream Infection Testing Market
9.6. Asia-Pacific Bloodstream Infection Testing Market Snapshot
9.6.1. China Bloodstream Infection Testing Market
9.6.2. India Bloodstream Infection Testing Market
9.6.3. Japan Bloodstream Infection Testing Market
9.6.4. Australia Bloodstream Infection Testing Market
9.6.5. South Korea Bloodstream Infection Testing Market
9.6.6. Rest of Asia Pacific Bloodstream Infection Testing Market
9.7. Latin America Bloodstream Infection Testing Market Snapshot
9.7.1. Brazil Bloodstream Infection Testing Market
9.7.2. Mexico Bloodstream Infection Testing Market
9.8. Middle East & Africa Bloodstream Infection Testing Market
9.8.1. Saudi Arabia Bloodstream Infection Testing Market
9.8.2. South Africa Bloodstream Infection Testing Market
9.8.3. Rest of Middle East & Africa Bloodstream Infection Testing Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Key Company SWOT Analysis
10.1.1. Company
10.1.2. Company
10.1.3. Company
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. BioMйrieux SA
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Becton, Dickinson and Company
10.3.3. Cepheid.
10.3.4. Seegene Inc.
10.3.5. T2 Biosystems, Inc.
10.3.6. F. Hoffmann-La Roche Ltd
10.3.7. Siemens Healthcare GmbH
10.3.8. Luminex Corporation.
10.3.9. Bruker
10.3.10. Accelerate Diagnostics, Inc.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Bloodstream Infection Testing Market, by Region, 2020-2030 (USD Million)
1.2.2. Bloodstream Infection Testing Market, by Product, 2020-2030 (USD Million)
1.2.3. Bloodstream Infection Testing Market, by Sample Type, 2020-2030 (USD Million)
1.2.4. Bloodstream Infection Testing Market, by Technology, 2020-2030 (USD Million)
1.2.5. Bloodstream Infection Testing Market, by End-use, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL BLOODSTREAM INFECTION TESTING MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL BLOODSTREAM INFECTION TESTING MARKET DYNAMICS
3.1. Bloodstream Infection Testing Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing burden of infectious diseases
3.1.1.2. Rising number of blood donations campaign
3.1.2. Market Challenges
3.1.2.1. High diagnosis cost
3.1.2.2. Lower investments in underdeveloped countries
3.1.3. Market Opportunities
3.1.3.1. Rise in the development of rapid point-of-care testing solutions
3.1.3.2. Increasing use of invasive medical devices
CHAPTER 4. GLOBAL BLOODSTREAM INFECTION TESTING MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL BLOODSTREAM INFECTION TESTING MARKET, BY PRODUCT
5.1. Market Snapshot
5.2. Global Bloodstream Infection Testing Market by Product, Performance - Potential Analysis
5.3. Global Bloodstream Infection Testing Market Estimates & Forecasts by Product 2020-2030 (USD Million)
5.4. Bloodstream Infection Testing Market, Sub Segment Analysis
5.4.1. Reagents & Consumables
5.4.2. Instruments
CHAPTER 6. GLOBAL BLOODSTREAM INFECTION TESTING MARKET, BY SAMPLE TYPE
6.1. Market Snapshot
6.2. Global Bloodstream Infection Testing Market by Sample Type, Performance - Potential Analysis
6.3. Global Bloodstream Infection Testing Market Estimates & Forecasts by Sample Type 2020-2030 (USD Million)
6.4. Bloodstream Infection Testing Market, Sub Segment Analysis
6.4.1. Whole Blood
6.4.2. Blood Culture
CHAPTER 7. GLOBAL BLOODSTREAM INFECTION TESTING MARKET, BY TECHNOLOGY
7.1. Market Snapshot
7.2. Global Bloodstream Infection Testing Market by Technology, Performance - Potential Analysis
7.3. Global Bloodstream Infection Testing Market Estimates & Forecasts by Technology 2020-2030 (USD Million)
7.4. Bloodstream Infection Testing Market, Sub Segment Analysis
7.4.1. PCR
7.4.2. Mass Spectroscopy
7.4.3. In Situ Hybridization
7.4.4. Others
CHAPTER 8. BLOODSTREAM INFECTION TESTING MARKET, BY END-USE
8.1. Market Snapshot
8.2. Global Bloodstream Infection Testing Market by End-use, Performance - Potential Analysis
8.3. Global Bloodstream Infection Testing Market Estimates & Forecasts by End-use 2020-2030 (USD Million)
8.4. Bloodstream Infection Testing Market, Sub Segment Analysis
8.4.1. Hospitals & Diagnostic Centers
8.4.2. Custom Laboratory Service Providers
8.4.3. Academic & Research Institutes
8.4.4. Others
CHAPTER 9. GLOBAL BLOODSTREAM INFECTION TESTING MARKET, REGIONAL ANALYSIS
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Bloodstream Infection Testing Market, Regional Market Snapshot
9.4. North America Bloodstream Infection Testing Market
9.4.1. U.S. Bloodstream Infection Testing Market
9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
9.4.1.2. Sample Type breakdown estimates & forecasts, 2020-2030
9.4.1.3. Technology breakdown estimates & forecasts, 2020-2030
9.4.1.4. End-use breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Bloodstream Infection Testing Market
9.5. Europe Bloodstream Infection Testing Market Snapshot
9.5.1. U.K. Bloodstream Infection Testing Market
9.5.2. Germany Bloodstream Infection Testing Market
9.5.3. France Bloodstream Infection Testing Market
9.5.4. Spain Bloodstream Infection Testing Market
9.5.5. Italy Bloodstream Infection Testing Market
9.5.6. Rest of Europe Bloodstream Infection Testing Market
9.6. Asia-Pacific Bloodstream Infection Testing Market Snapshot
9.6.1. China Bloodstream Infection Testing Market
9.6.2. India Bloodstream Infection Testing Market
9.6.3. Japan Bloodstream Infection Testing Market
9.6.4. Australia Bloodstream Infection Testing Market
9.6.5. South Korea Bloodstream Infection Testing Market
9.6.6. Rest of Asia Pacific Bloodstream Infection Testing Market
9.7. Latin America Bloodstream Infection Testing Market Snapshot
9.7.1. Brazil Bloodstream Infection Testing Market
9.7.2. Mexico Bloodstream Infection Testing Market
9.8. Middle East & Africa Bloodstream Infection Testing Market
9.8.1. Saudi Arabia Bloodstream Infection Testing Market
9.8.2. South Africa Bloodstream Infection Testing Market
9.8.3. Rest of Middle East & Africa Bloodstream Infection Testing Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Key Company SWOT Analysis
10.1.1. Company
10.1.2. Company
10.1.3. Company
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. BioMйrieux SA
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Becton, Dickinson and Company
10.3.3. Cepheid.
10.3.4. Seegene Inc.
10.3.5. T2 Biosystems, Inc.
10.3.6. F. Hoffmann-La Roche Ltd
10.3.7. Siemens Healthcare GmbH
10.3.8. Luminex Corporation.
10.3.9. Bruker
10.3.10. Accelerate Diagnostics, Inc.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Bloodstream Infection Testing Market, report scope
TABLE 2. Global Bloodstream Infection Testing Market estimates & forecasts by Region 2020-2030 (USD Million)
TABLE 3. Global Bloodstream Infection Testing Market estimates & forecasts by Product 2020-2030 (USD Million)
TABLE 4. Global Bloodstream Infection Testing Market estimates & forecasts by Sample Type 2020-2030 (USD Million)
TABLE 5. Global Bloodstream Infection Testing Market estimates & forecasts by Technology 2020-2030 (USD Million)
TABLE 6. Global Bloodstream Infection Testing Market estimates & forecasts by End-use 2020-2030 (USD Million)
TABLE 7. Global Bloodstream Infection Testing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 8. Global Bloodstream Infection Testing Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 9. Global Bloodstream Infection Testing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 10. Global Bloodstream Infection Testing Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 11. Global Bloodstream Infection Testing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 12. Global Bloodstream Infection Testing Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 13. Global Bloodstream Infection Testing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 14. Global Bloodstream Infection Testing Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 15. Global Bloodstream Infection Testing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 16. Global Bloodstream Infection Testing Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 17. U.S. Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 18. U.S. Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 19. U.S. Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 20. Canada Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 21. Canada Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 22. Canada Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 23. UK Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 24. UK Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 25. UK Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 26. Germany Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 27. Germany Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 28. Germany Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 29. France Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 30. France Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 31. France Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 32. Italy Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 33. Italy Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 34. Italy Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 35. Spain Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 36. Spain Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 37. Spain Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 38. RoE Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 39. RoE Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 40. RoE Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 41. China Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 42. China Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 43. China Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 44. India Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 45. India Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 46. India Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 47. Japan Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 48. Japan Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 49. Japan Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 50. South Korea Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 51. South Korea Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 52. South Korea Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 53. Australia Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 54. Australia Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 55. Australia Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 56. RoAPAC Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 57. RoAPAC Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 58. RoAPAC Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 59. Brazil Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 60. Brazil Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 61. Brazil Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 62. Mexico Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 63. Mexico Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 64. Mexico Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 65. RoLA Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 66. RoLA Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 67. RoLA Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 68. Saudi Arabia Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 69. South Africa Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 70. RoMEA Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 71. List of secondary sources, used in the study of global Bloodstream Infection Testing Market
TABLE 72. List of primary sources, used in the study of global Bloodstream Infection Testing Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Bloodstream Infection Testing Market, report scope
TABLE 2. Global Bloodstream Infection Testing Market estimates & forecasts by Region 2020-2030 (USD Million)
TABLE 3. Global Bloodstream Infection Testing Market estimates & forecasts by Product 2020-2030 (USD Million)
TABLE 4. Global Bloodstream Infection Testing Market estimates & forecasts by Sample Type 2020-2030 (USD Million)
TABLE 5. Global Bloodstream Infection Testing Market estimates & forecasts by Technology 2020-2030 (USD Million)
TABLE 6. Global Bloodstream Infection Testing Market estimates & forecasts by End-use 2020-2030 (USD Million)
TABLE 7. Global Bloodstream Infection Testing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 8. Global Bloodstream Infection Testing Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 9. Global Bloodstream Infection Testing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 10. Global Bloodstream Infection Testing Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 11. Global Bloodstream Infection Testing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 12. Global Bloodstream Infection Testing Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 13. Global Bloodstream Infection Testing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 14. Global Bloodstream Infection Testing Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 15. Global Bloodstream Infection Testing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 16. Global Bloodstream Infection Testing Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 17. U.S. Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 18. U.S. Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 19. U.S. Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 20. Canada Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 21. Canada Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 22. Canada Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 23. UK Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 24. UK Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 25. UK Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 26. Germany Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 27. Germany Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 28. Germany Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 29. France Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 30. France Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 31. France Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 32. Italy Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 33. Italy Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 34. Italy Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 35. Spain Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 36. Spain Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 37. Spain Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 38. RoE Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 39. RoE Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 40. RoE Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 41. China Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 42. China Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 43. China Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 44. India Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 45. India Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 46. India Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 47. Japan Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 48. Japan Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 49. Japan Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 50. South Korea Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 51. South Korea Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 52. South Korea Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 53. Australia Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 54. Australia Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 55. Australia Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 56. RoAPAC Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 57. RoAPAC Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 58. RoAPAC Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 59. Brazil Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 60. Brazil Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 61. Brazil Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 62. Mexico Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 63. Mexico Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 64. Mexico Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 65. RoLA Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 66. RoLA Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 67. RoLA Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 68. Saudi Arabia Bloodstream Infection Testing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 69. South Africa Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 70. RoMEA Bloodstream Infection Testing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 71. List of secondary sources, used in the study of global Bloodstream Infection Testing Market
TABLE 72. List of primary sources, used in the study of global Bloodstream Infection Testing Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Bloodstream Infection Testing Market, research methodology
FIG 2. Global Bloodstream Infection Testing Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Bloodstream Infection Testing Market, key trends 2022
FIG 5. Global Bloodstream Infection Testing Market, growth prospects 2023-2030
FIG 6. Global Bloodstream Infection Testing Market, porters 5 force model
FIG 7. Global Bloodstream Infection Testing Market, pest analysis
FIG 8. Global Bloodstream Infection Testing Market, value chain analysis
FIG 9. Global Bloodstream Infection Testing Market by segment, 2020 & 2030 (USD Million)
FIG 10. Global Bloodstream Infection Testing Market by segment, 2020 & 2030 (USD Million)
FIG 11. Global Bloodstream Infection Testing Market by segment, 2020 & 2030 (USD Million)
FIG 12. Global Bloodstream Infection Testing Market by segment, 2020 & 2030 (USD Million)
FIG 13. Global Bloodstream Infection Testing Market by segment, 2020 & 2030 (USD Million)
FIG 14. Global Bloodstream Infection Testing Market, regional snapshot 2020 & 2030
FIG 15. North America Bloodstream Infection Testing Market 2020 & 2030 (USD Million)
FIG 16. Europe Bloodstream Infection Testing Market 2020 & 2030 (USD Million)
FIG 17. Asia pacific Bloodstream Infection Testing Market 2020 & 2030 (USD Million)
FIG 18. Latin America Bloodstream Infection Testing Market 2020 & 2030 (USD Million)
FIG 19. Middle East & Africa Bloodstream Infection Testing Market 2020 & 2030 (USD Million)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Bloodstream Infection Testing Market, research methodology
FIG 2. Global Bloodstream Infection Testing Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Bloodstream Infection Testing Market, key trends 2022
FIG 5. Global Bloodstream Infection Testing Market, growth prospects 2023-2030
FIG 6. Global Bloodstream Infection Testing Market, porters 5 force model
FIG 7. Global Bloodstream Infection Testing Market, pest analysis
FIG 8. Global Bloodstream Infection Testing Market, value chain analysis
FIG 9. Global Bloodstream Infection Testing Market by segment, 2020 & 2030 (USD Million)
FIG 10. Global Bloodstream Infection Testing Market by segment, 2020 & 2030 (USD Million)
FIG 11. Global Bloodstream Infection Testing Market by segment, 2020 & 2030 (USD Million)
FIG 12. Global Bloodstream Infection Testing Market by segment, 2020 & 2030 (USD Million)
FIG 13. Global Bloodstream Infection Testing Market by segment, 2020 & 2030 (USD Million)
FIG 14. Global Bloodstream Infection Testing Market, regional snapshot 2020 & 2030
FIG 15. North America Bloodstream Infection Testing Market 2020 & 2030 (USD Million)
FIG 16. Europe Bloodstream Infection Testing Market 2020 & 2030 (USD Million)
FIG 17. Asia pacific Bloodstream Infection Testing Market 2020 & 2030 (USD Million)
FIG 18. Latin America Bloodstream Infection Testing Market 2020 & 2030 (USD Million)
FIG 19. Middle East & Africa Bloodstream Infection Testing Market 2020 & 2030 (USD Million)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
